PBIO (Pressure BioSciences) Beneish M-Score: 0.00 (As of Jul. 11, 2026)

What is Pressure BioSciences Beneish M-Score?

Pressure BioSciences PBIO -71.43% 12 Beneish M-Score is 0.00 as of Jul. 11, 2026. GuruFocus rates PBIO with a GF Score™ of 12/100.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Pressure BioSciences's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Pressure BioSciences was 0.00. The lowest was 0.00. And the median was 0.00.

Pressure BioSciences Beneish M-Score Related Terms

Pressure BioSciences Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Pressure BioSciences's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pressure BioSciences Beneish M-Score Chart

Pressure BioSciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beneish M-Score

Get a 7-Day Free Trial

-14.23

-19.32

-25.01

-29.28

-101.99

Pressure BioSciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Beneish M-Score	Get a 7-Day Free Trial															-107.94	-64.35	-101.99	-15.33	-14.35

PBIO vs EMED, CUTRQ, MHTX: Beneish M-Score Comparison

For the Medical Devices subindustry, Pressure BioSciences's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pressure BioSciences Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pressure BioSciences's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Pressure BioSciences's Beneish M-Score falls into.

Save Embed

12GF Score

Pressure BioSciences Inc PBIO

Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Pressure BioSciences Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Pressure BioSciences for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 1.3041

0.528 * -0.0208

0.404 * 3.6417

0.892 * 0.7465

0.115 * 1.1745

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 1.5306

4.679 * -2.688472

0.327 * 0.4011

-14.35

This Year (Jun24) TTM:

Last Year (Jun23) TTM:

Total Receivables was $0.18 Mil.
Revenue was 0.422 + 0.349 + 0.312 + 0.413 = $1.50 Mil.
Gross Profit was 0.044 + 0.116 + -0.021 + 0.184 = $0.32 Mil.
Total Current Assets was $0.87 Mil.
Total Assets was $6.88 Mil.
Property, Plant and Equipment(Net PPE) was $0.65 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.22 Mil.
Selling, General, & Admin. Expense(SGA) was $7.30 Mil.
Total Current Liabilities was $43.58 Mil.
Long-Term Debt & Capital Lease Obligation was $0.52 Mil.
Net Income was -7.116 + -8.074 + -9.904 + -5.63 = $-30.72 Mil.
Non Operating Income was -1.654 + -1.205 + -4.943 + 0.002 = $-7.80 Mil.
Cash Flow from Operations was -0.706 + -1.86 + -1.132 + -0.732 = $-4.43 Mil.

Total Receivables was $0.19 Mil.
Revenue was 0.512 + 0.741 + 0.607 + 0.144 = $2.00 Mil.
Gross Profit was 0.255 + 0.382 + -0.664 + 0.018 = $-0.01 Mil.
Total Current Assets was $1.05 Mil.
Total Assets was $1.68 Mil.
Property, Plant and Equipment(Net PPE) was $0.27 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.11 Mil.
Selling, General, & Admin. Expense(SGA) was $6.39 Mil.
Total Current Liabilities was $26.54 Mil.
Long-Term Debt & Capital Lease Obligation was $0.24 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.184 / 1.496)	/	(0.189 / 2.004)
	=	0.122995	/	0.094311
	=	1.3041

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(-0.009 / 2.004)	/	(0.323 / 1.496)
	=	-0.004491	/	0.215909
	=	-0.0208

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (0.874 + 0.654) / 6.879)	/	(1 - (1.049 + 0.269) / 1.676)
	=	0.777875	/	0.213604
	=	3.6417

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	1.496	/	2.004
	=	0.7465

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.114 / (0.114 + 0.269))	/	(0.222 / (0.222 + 0.654))
	=	0.29765	/	0.253425
	=	1.1745

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(7.3 / 1.496)	/	(6.389 / 2.004)
	=	4.879679	/	3.188124
	=	1.5306

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0.519 + 43.575) / 6.879)	/	((0.244 + 26.541) / 1.676)
	=	6.409943	/	15.981504
	=	0.4011

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-30.724 - -7.8	-	-4.43)	/	6.879
	=	-2.688472

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Pressure BioSciences has a M-score of -14.35 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of 0.00 mean?

Pressure BioSciences (PBIO) has a Beneish M-Score of 0.00 as of Jul. 11, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Pressure BioSciences and its competitors.

Is Pressure BioSciences' Beneish M-Score too high?

Pressure BioSciences' current Beneish M-Score is 0.00. Overall, Pressure BioSciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Pressure BioSciences' Beneish M-Score compare to EMED and CUTRQ?

Pressure BioSciences' Beneish M-Score of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Medical Devices & Instruments company?

A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Pressure BioSciences and its competitors. Pressure BioSciences's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Pressure BioSciences stock overvalued right now?

Pressure BioSciences (PBIO) has a current Beneish M-Score of 0.00. The current Beneish M-Score is 0.00. Pressure BioSciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For Pressure BioSciences (PBIO), the current Beneish M-Score is 0.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pressure BioSciences Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies EMED CUTRQ MHTX AFIB TBIO AXDXQ BIOLQ SONX ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD XAMS:PHIA XSWX:SOON

Address 14 Norfolk Avenue, South Easton, MA, USA, 02375

Website https://www.pressurebiosciences.com

Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.

12GF Score

Get the complete analysis for PBIO

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View PBIO Analysis

See Beneish M-Score data for all stocks →